Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 2, 2007, Pages

  Perucca, Julie ^a   Bouby, Nadine ^a   Valeix, Pierre ^b   Bankir, Lise ^a  

^a INSERM   (France)

^b Bioinformatique et Chimie Moléculaire   (France)

Author keywords

Hypertension; Lithiasis; Thirst; Urine volume; Vasopressin

Indexed keywords

CREATININE;

CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; FOOD INTAKE; HUMAN; KIDNEY CONCENTRATING CAPACITY; KIDNEY DISEASE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SODIUM EXCRETION; SODIUM INTAKE; URINALYSIS; URINE OSMOLALITY; URINE VOLUME;

ADOLESCENT; ADULT; AGED; AGING; FEMALE; HUMANS; KIDNEY CONCENTRATING ABILITY; KIDNEY DISEASES; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; SEX CHARACTERISTICS; SODIUM, DIETARY;

EID: 33846787015     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00500.2006     Document Type: Review

References (67)

1. Bakris G, Bursztyn M, Gavras I, Bresnahan M, Gavras H. Role of vasopressin in essential hypertension: racial differences. J Hypertens 15: 545-550, 1997.
2. Bankir L. Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc Res 51: 372-390, 2001.
3. Bankir L, Ahloulay M, Bardoux P. Vasopressin and diabetes mellitus. Nephron 87: 8-18, 2001.
4. Bankir L, Bardoux P, Mayaudon H, Dupuy O, Bauduceau B. Too low urinary flow rate during the day: new factor possibly involved in hypertension and in the lack of nocturnal dipping (in French). Arch Mal Coeur Vaiss 95: 751-754, 2002.
5. Bankir L, Bouby N, Ardaillou R, Bichet DG, Dussaule JC, Jungers P. Progressive increase in plasma vasopressin (AVP) and decrease in urine concentrating ability in chronic renal failure (CRF): influence of primary disease (Abstract). J Am Soc Nephrol 3: 733, 1992.
6. Bankir L, Bouby N, Trinh-Trang-Tan MM, Ahloulay M, and Promeneur D. Direct and indirect cost of urea excretion. Kidney Int 49: 1598-1607, 1996.
7. Bankir L, Fernandes S, Bardoux P, Bouby N, Bichet DG. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol 16: 1920-1928, 2005.
8. Bankir L, Kriz W. Adaptation of the kidney to protein intake and to urine concentrating activity: similar consequences in health and disease. Kidney Int 47: 7-24, 1995.
9. Bankir L, Pouzet B, Choukroun G, Bouby N, Schmitt F, Mallie JP. To concentrate the urine or to excrete sodium: two sometimes contradictory requirements (in French). Néphrologie 19: 203-209, 1998.
10. Bardoux P, Bichet DG, Martin H, Gallois Y, Marre M, Arthus MF, Lonergan M, Ruel N, Bouby N, Bankir L. Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system. Nephrol Dial Transplant 18: 497-506, 2003.
11. Bardoux P, Bruneval P, Heudes D, Bouby N, Bankir L. Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats. Nephrol Dial Transplant 18: 1755-1763, 2003.
12. Bardoux P, Martin H, Ahloulay M, Schmitt F, Bouby N, Trinh-Trang-Tan MM, and Bankir L. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats. Proc Natl Acad Sci USA 96: 10397-10402, 1999.
13. Baylis C. Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy Male gender as a primary risk factor. J Clin Invest 94: 1823-1829, 1994.
14. Berl T, Raz A, Wald H, Horowitz J, Czaczkes W. Prostaglandin synthesis inhibition and the action of vasopressin: studies in man and rat. Am J Physiol Renal Fluid Electrolyte Physiol 232: F529-F537, 1977.
15. Bichet DG, Razi M, Lonergan M, Arthus MF, Papukna V, Kortas C, Barjon JN. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 318: 881-887, 1988.
16. Bouby N, Ahloulay M, Nsegbe E, Dechaux M, Schmitt F, Bankir L. Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action. J Am Soc Nephrol 7: 842-851, 1996.
17. Bouby N, Bachmann S, Bichet D, Bankir L. Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat. Am J Physiol Renal Fluid Electrolyte Physiol 258: F973-F979, 1990.
18. Bouby N, Hassler C, Bankir L. Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats. Life Sci 65: 991-1004, 1999.
19. Choukroun G, Schmitt F, Martinez F, Drüeke T, Bankir L. Low urine flow rate reduces the capacity to excrete a sodium load in man. Am J Physiol Regul Integr Comp Physiol 273: R1726-R1733, 1997.
20. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 115: 2598-2608, 2005.
21. Cowley AW, Skelton MM, Velasquez MT. Sex differences in the endocrine predictors of essential hypertension. Vasopressin versus renin. Hypertension 7: I151-I160, 1985.
22. Crofton JT, Dustan H, Share L, Brooks DP. Vasopressin secretion in normotensive black and white men and women on normal and low sodium diets. J Endocrinol 108: 191-199, 1986.
23. Daudon M, Donsimoni R, Hennequin C, Fellahi S, Le Moel G, Paris M, Troupel S, Lacour B. Sex- and age-related composition of 10 617 calculi analyzed by infrared spectroscopy. Urol Res 23: 319-326, 1995.
24. Daudon M, Hennequin C, Boujelben G, Lacour B, Jungers P. Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int 67: 1934-1943, 2005.
25. Dixey JJ, Williams TD, Lightman SL, Lant AF, Brewerton DA. The effect of indomethacin on the renal response to arginine vasopressin in man. Clin Sci (Lond) 70: 409-416, 1986.
26. Ebner A, Manz F. Sex difference of urinary osmolality in German children. Am J Nephrol 22: 352-355, 2002.
27. Eloy L, Grünfeld JP, Bayle F, Ramos-Fremdo B, and Trinh-Trang-Tan MM. Papillary plasma flow in rats. II. Hormonal control. Pflügers Arch 398: 253-258, 1983.
28. Fernandes S, Bruneval P, Hagege A, Heudes D, Ghostine S, Bouby N. Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension. Endocrinology 143: 2759-2766, 2002.
29. Greenberg A, Verbalis JG. Vasopressin receptor antagonists. Kidney Int 69: 2124-2130, 2006.
30. Hadj-Aissa A, Bankir L, Fraysse M, Bichet DG, Laville M, Zech P, Pozet N. Influence of the level of hydration on the renal response to a protein meal. Kidney Int 42: 1207-1216, 1992.
31. Harvey AM, Malvin RL. Comparison of creatinine and inulin clearances in male and female rats. Am J Physiol 209: 849-852, 1965.
32. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briancon S. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164: 2335-2342, 2004.
33. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 18: 2024-2031, 2003.
34. Izzat NN, Rosborough JP. Renal function in conscious dogs: potential effect of gender on measurement. Res Exp Med (Berl) 189: 371-379, 1989.
35. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254, 2006.
36. Lew SQ, Bosch JP. Effect of diet on creatinine clearance and excretion in young and elderly healthy subjects and in patients with renal disease. J Am Soc Nephrol 2: 856-865, 1991.
37. Lieberthal W, Vasilevsky ML, Valari CR, Levinsky NG. Interactions between ADH and prostaglandins in isolated erythrocyte-perfused rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 252: F331-F337, 1987.
38. Luft FC, Grim CE, Fineberg N, Weinberger MC. Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation 59: 643-650, 1979.
39. Namnum P, Insogna K, Baggish D, Hayslett JP. Evidence for bidirectional net movement of creatinine in the rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 244: F719-F723, 1983.
40. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 11: 319-329, 2000.
41. Nicco C, Wittner M, DiStefano A, Jounier S, Bankir L, Bouby N. Chronic exposure to vasopressin upregulates ENaC and sodium transport in the rat collecting duct and lung. Hypertension 38: 1143-1149, 2001.
42. O'Connel JMB, Romeo JA, Mudge GH. Renal tubular secretion of creatinine in the dog. Am J Physiol 203: 985-990, 1962.
43. Ota M, Crofton JT, Liu H, Festavan G, Share L. Increased plasma osmolality stimulates peripheral and central vasopressin release in male and female rats. Am J Physiol Regul Integr Comp Physiol 267: R923-R928, 1994.
44. Oudar O, Elger M, Bankir L, Ganten D, Ganten U, Kriz W. Differences in rat kidney morphology between males, females and testosterone-treated females. Renal Physiol Biochem 14: 92-102, 1991.
45. Parekh N, Zou AP, Jungling I, Endlich K, Sadowski J, Steinhausen M. Sex differences in control of renal outer medullary circulation in rats: role of prostaglandins. Am J Physiol Renal Fluid Electrolyte Physiol 264: F629-F636, 1993.
46. Parks JH, Barsky R, Coe FL. Gender differences in seasonal variation of urine stone risk factors. J Urol 170: 384-388, 2003.
47. Remuzzi A, Puntorieri S, Mazzoleni A, Remuzzi G. Sex related differences in glomerular ultrafiltration and proteinuria in Munich-Wistar rats. Kidney Int 34: 481-486, 1988.
48. Reyes D, Lew SQ, Kimmel PL. Gender differences in hypertension and kidney disease. Med Clin North Am 89: 613-630, 2005.
49. Rule AD, Torres VE, Chapman AB, Grantham JJ, Guay-Woodford LM, Bae KT, Klahr S, Bennett WM, Meyers CM, Thompson PA, Miller JP. Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort. J Am Soc Nephrol 17: 854-862, 2006.
50. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344: 3-10, 2001.
51. Sandberg K, Ji H. Sex and the renin angiotensin system: implications for gender differences in the progression of kidney disease. Adv Ren Replace Ther 10: 15-23, 2003.
52. Schafer JA. Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct. Am J Physiol Renal Physiol 283: F221-F235, 2002.
53. Serradeil-Le-Gal C, Lacour C, Valette G, Garcia G, Foulon L, Galindo G, Bankir L, Pouzet B, Guillon G, Barberis C, Chicot D, Jard S, Vilain P, Garcia C, Marty E, Raufaste D, Brossard G, Nisato D, Maffrand JP, and Le-Fur G. Charaterization of SR 121463A, a highly potent and selective orally active vasopressin V2 receptor antagonist. J Clin Invest 98: 2729-2738, 1996.
54. Share L, Crofton JT, Ouchi Y. Vasopressin: sexual dimorphism in secretion, cardiovascular actions and hypertension. Am J Med Sci 295: 314-319, 1988.
55. Share L, Wang YX, Crofton JT. Gender differences in the actions of vasopressin. In: Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research, edited by Saito T, Kurokawa K, and Yoshida S. Amsterdam: Elsevier, 1995, p. 3-13.
56. Stachenfeld NS, Splenser AE, Calzone WL, Taylor MP, Keefe DL. Sex differences in osmotic regulation of AVP and renal sodium handling. J Appl Physiol 91: 1893-1901, 2001.
57. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63: 1817-1823, 2003.
58. Stringer KD, Komers R, Osman SA, Oyama TT, Lindsley JN, Anderson S. Gender hormones and the progression of experimental polycystic kidney disease. Kidney Int 68: 1729-1739, 2005.
59. Sugiura T, Yamauchi A, Kitamura H, Matsuoka Y, Horio M, Imai E, Hori M. High water intake ameliorates tubulointerstitial injury in rats with subtotal nephrectomy: possible role of TGF-β. Kidney Int 55: 1800-1810, 1999.
60. Sullivan JC, Sasser JM, Pollock DM, Pollock JS. Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats. Hypertension 45: 406-411, 2005.
61. Wang YX, Crofton JT, Liu H, Sato K, Brooks DP, Share L. Estradiol attenuates the antidiuretic action of vasopressin in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 268: R951-R957, 1995.
62. Wang YX, Crofton JT, Miller J, Sigman CJ, Liu H, Huber JM, Brooks DP, Share L. Sex difference in urinary concentrating ability of rats with water deprivation. Am J Physiol Regul Integr Comp Physiol 270: R550-R555, 1996.
63. Wang YX, Crofton JT, Share L. Sex differences in the cardiovascular and renal actions of vasopressin in conscious rats. Am J Physiol Regul Integr Comp Physiol 272: R370-R376, 1997.
64. Wang YX, Edwards RM, Nambi P, Stack EJ, Pullen M, Share L, Crofton JT, Brooks DP. Sex difference in the antidiuretic activity of vasopressin in the rat. Am J Physiol Regul Integr Comp Physiol 265: R1284-R1290, 1993.
65. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 8: II127-II134, 1986.
66. Zeier M, Gafter U, Ritz E. Renal function and renal disease in males or females-vive la petite difference. Nephrol Dial Transplant 13: 2195-2198, 1998.
67. Zerbe RL, Miller JZ, Robertson GL. The reproductibility and heritability of individual differences in osmoregulatory function in normal human. J Lab Clin Med 117: 51-59, 1991.